Tag: FDA’s Drug


The Biopharmaceutical Industry Provides 75% Of The FDA’s Drug Review Budget — Is This A Problem?

June 28, 2018

Via: Forbes

Caroline Chen of ProPublica has written a provocative article challenging the objectivity of the FDA in its approval of new drugs. Entitled: “FDA Repays Industry by Rushing Risky Drugs to Market”, Chen contends that the agency is beholden to the […]